Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Anebulo Pharmaceuticals, Inc. (ANEB)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 |
| | 10-K | 10-K | 8-K |
| Revenues | | | 100.0% |
| Cost of goods sold | | | 115.6% |
| Gross profit | | | -15.6% |
| General and administrative | | | 15.6% |
| EBIT | | | -115.6% |
| Pre-tax income | | | -116.4% |
| Income taxes | | | 0.0% |
| Net income | | | -116.4% |
|